OPTIMIZING HORMONES FOR ULTIMATE HEALTH
At Wdowin NMD we treat a number of hormone related conditions and work with patients that are experiencing age related health conditions everyday. It is a known fact that as the body ages, hormone production decreases, and because hormones control thousands of different bodily functions, thousands of symptoms can manifest due to hormonal imbalances.
For women, hormones begin to decline during a stage known as peri-menopause, which occurs around 4-6 years before menopause. During this stage hormones like estrogen, DHEA, testosterone and progesterone decrease, and after one full year of no menstruation, a woman has technically entered menopause.
Men also experience hormone decline, and this period of hormone decline is known as andropause. For men, hormones like DHEA, growth hormone and testosterone typically begins to decrease at around age 30 (yet with increased stress and toxicity the decrease can begin sooner), and by 40 there is typically a steady decline.
Hormonal imbalances are not only related to aging and can be initiated with increased exposures to environmental toxins including heavy metals like mercury and cadmium, as well as solvents and phthalates (plastics). Other factors for hormone levels include stress, poor dietary choices, and lifestyle habits, and nutritional deficiencies.
At Wdowin NMD there are three stages to bio-identical hormone therapy.
- lifestyle, nutrition and herbal interventions to support the body's natural production.
- Secretagogues to stimulate the body to make more of a hormone.
- Hormone replacement where the actual hormone is added to the body.
Bio-identical hormones are unique because their molecular structure is identical to the structure of the hormones made by the human body. This can reduce side effects and allow the body to easily accept the hormone supplementation. Synthetic hormones like Premarin are not bio-identical therefore not an identical match created by the human body and can cause negative side effects, such as an increased risk of hormone sensitive cancers.